HK1093012172
HK1093012172
CSPC PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 103.62B EUR | 79.5B EUR | 103.77B EUR |
Enterprise Value | 87.66B EUR | 70.15B EUR | 103.77B EUR |
Valuation Multiples | |||
Trailing P/E | 13.17x | -- | -- |
Forward P/E | 13.63x | -- | -- |
Price to Sales | 3.31x | -- | -- |
Price to Book | 2.35x | 2.11x | -- |
EV/Revenue | 2.8x | -- | -- |
EV/EBITDA | 8.88x | -- | -- |
Price to FCF (P/FCF) | 10.47x | -- | -- |
EV/FCF | 8.86x | -- | -- |
FCF Yield | 9.55% | -- | -- |